GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Eurofins Scientific SE (OTCPK:ERFSF) » Definitions » EV-to-EBIT
中文

Eurofins Scientific SE (Eurofins Scientific SE) EV-to-EBIT : 25.88 (As of Apr. 25, 2024)


View and export this data going back to . Start your Free Trial

What is Eurofins Scientific SE EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Eurofins Scientific SE's Enterprise Value is $15,547 Mil. Eurofins Scientific SE's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $601 Mil. Therefore, Eurofins Scientific SE's EV-to-EBIT for today is 25.88.

The historical rank and industry rank for Eurofins Scientific SE's EV-to-EBIT or its related term are showing as below:

ERFSF' s EV-to-EBIT Range Over the Past 10 Years
Min: 12.53   Med: 30.29   Max: 46.05
Current: 25.88

During the past 13 years, the highest EV-to-EBIT of Eurofins Scientific SE was 46.05. The lowest was 12.53. And the median was 30.29.

ERFSF's EV-to-EBIT is ranked worse than
57.94% of 107 companies
in the Medical Diagnostics & Research industry
Industry Median: 20.2 vs ERFSF: 25.88

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Eurofins Scientific SE's Enterprise Value for the quarter that ended in Dec. 2023 was $15,365 Mil. Eurofins Scientific SE's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $601 Mil. Eurofins Scientific SE's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 3.91%.


Eurofins Scientific SE EV-to-EBIT Historical Data

The historical data trend for Eurofins Scientific SE's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eurofins Scientific SE EV-to-EBIT Chart

Eurofins Scientific SE Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 32.93 19.25 20.13 17.86 25.49

Eurofins Scientific SE Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 20.13 - 17.86 - 25.49

Competitive Comparison of Eurofins Scientific SE's EV-to-EBIT

For the Diagnostics & Research subindustry, Eurofins Scientific SE's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Eurofins Scientific SE's EV-to-EBIT Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Eurofins Scientific SE's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Eurofins Scientific SE's EV-to-EBIT falls into.



Eurofins Scientific SE EV-to-EBIT Calculation

Eurofins Scientific SE's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=15546.733/600.75
=25.88

Eurofins Scientific SE's current Enterprise Value is $15,547 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Eurofins Scientific SE's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $601 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Eurofins Scientific SE  (OTCPK:ERFSF) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Eurofins Scientific SE's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 ) =EBIT / Enterprise Value (Q: Dec. 2023 )
=600.75/15364.61275
=3.91 %

Eurofins Scientific SE's Enterprise Value for the quarter that ended in Dec. 2023 was $15,365 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Eurofins Scientific SE's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $601 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Eurofins Scientific SE EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Eurofins Scientific SE's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Eurofins Scientific SE (Eurofins Scientific SE) Business Description

Traded in Other Exchanges
Address
23 Val Fleuri, Luxembourg, LUX, L-1526
Eurofins, headquartered in Luxembourg, is a decentralized network of life sciences companies that provide various analytical tests and laboratory services. These include tests to evaluate the safety, identity, composition, authenticity, purity, origin, and traceability of various biological substances and products. Eurofins operates over 900 laboratories in 61 countries. Its revenue from Europe, North America, and the Rest of the World contribute approximately 50%, 40%, and 10% of total revenue respectively. Its main business activities are food and environmental testing, biopharmaceutical services, diagnostic services and products, and consumer and technology products testing, which contribute approximately 40%, 30%, 20%, and 10% respectively.